Principal Financial Group Inc. Raises Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Principal Financial Group Inc. lifted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 21.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 24,953,351 shares of the real estate investment trust’s stock after acquiring an additional 4,431,897 shares during the period. Principal Financial Group Inc. owned approximately 0.10% of Sabra Healthcare REIT worth $472,617,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of SBRA. Founders Capital Management purchased a new stake in shares of Sabra Healthcare REIT during the third quarter valued at approximately $28,000. Danske Bank A S purchased a new stake in shares of Sabra Healthcare REIT during the third quarter valued at approximately $30,000. Larson Financial Group LLC increased its position in shares of Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the last quarter. First Horizon Corp purchased a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at approximately $44,000. Finally, Covestor Ltd increased its position in shares of Sabra Healthcare REIT by 23,720.0% during the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after acquiring an additional 2,372 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.46 on Tuesday. The stock has a fifty day simple moving average of $20.23 and a two-hundred day simple moving average of $19.36. Sabra Healthcare REIT, Inc. has a 1-year low of $17.04 and a 1-year high of $21.07. The firm has a market cap of $5.16 billion, a price-to-earnings ratio of 32.48, a price-to-earnings-growth ratio of 1.63 and a beta of 0.67. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $221.75 million during the quarter, compared to analyst estimates of $209.20 million. During the same period in the prior year, the company earned $0.37 earnings per share. Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Wall Street Analyst Weigh In

A number of analysts recently commented on SBRA shares. Citigroup increased their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Citizens Jmp increased their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Weiss Ratings lowered Sabra Healthcare REIT from a “buy (a-)” rating to a “buy (b+)” rating in a report on Friday. Scotiabank increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a report on Monday, March 2nd. Finally, Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a report on Thursday, March 26th. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $22.00.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.